The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
Транспортер аминокислот L-типа LAT1 — перспективная мишень при раке
2019-05-16
SCID: 54.1/5f7u439y
Discuss with AI
L-type amino acid transporter LAT1SLC7A5canceressential amino acid uptaketherapeutic target
Figures from the paper
Abstract (AI)
Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across the cell membrane is tightly controlled by membrane transporters. Among those, the L-type amino acid transporter LAT1 (SLC7A5) has been repeatedly found overexpressed in a vast variety of cancers. In this review, we summarize the most recent advances in our understanding of the role of LAT1 in cancer and highlight preclinical studies and drug developments underlying the potential of LAT1 as therapeutic target.
Key Findings
1
LAT1 (SLC7A5) is a membrane transporter that tightly regulates amino-acid uptake in cancer cells.
2
LAT1 is repeatedly reported to be overexpressed across a wide variety of cancers.
3
Rapidly proliferating cancer cells depend on essential amino acids to duplicate cell mass during each division.
4
Recent preclinical studies and drug-development efforts support LAT1 as a potential therapeutic target in oncology.
5
The review summarizes advances in understanding LAT1’s role in cancer and evaluates its therapeutic potential.
Research Object
L-type amino acid transporter LAT1 (SLC7A5) in cancer cells
Research Subject
LAT1 overexpression, role in cancer cell amino acid uptake and proliferation, and its potential as a therapeutic target
Publication Details
Publication Date
2019-05-16
Journal
Publisher
ISSN
Cited by
232
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by8
Metabolism of Amino Acids in Cancer2021
L-Type amino acid transporter 1 as a target for drug delivery2020
Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment2020
ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation2021
Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods2018
Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine2022
L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review)2025
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-2112024